TELA Bio, Inc. (TELA) Q4 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Tela Bio, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:04.277 Good afternoon, ladies and gentlemen, and welcome to the Telebio fourth quarter and full 00:00:04.277 -- 00:00:09.725 year 2025 earnings conference call. At this time, all participants are in listen-only 00:00:09.725 -- 00:00:14.051 mode. A question and answer session will follow the prepared remarks. 00:00:14.051 -- 00:00:16.534 As a reminder, this conference call is being recorded. 00:00:16.534 -- 00:00:21.662 I would now like to turn the conference call over to Louisa Smith from Invest 00:00:21.662 -- 00:00:23.662 Relations. 00:00:24.706 -- 00:00:28.567 Thank you, Jonathan, and good afternoon, everyone. 00:00:28.567 -- 00:00:33.674 Earlier today, Telebio released financial results for the fourth quarter and 00:00:33.674 -- 00:00:37.416 full year ended December 31, 2025. 00:00:38.180 -- 00:00:42.426 A copy of the press release is available on the company's website. 00:00:42.426 -- 00:00:47.853 Joining me on today's call are Tony Koblish, Chief Executive Officer, Jeff 00:00:47.853 -- 00:00:53.065 Blizzard, President, Roberto Cuca, Chief Operating Officer and Chief 00:00:53.065 -- 00:00:58.353 Financial Officer, and Jim Hagan, Senior Vice President of Strategic Operations 00:00:58.353 -- 00:01:03.361 and Marketing. Before we begin, I'd like to remind you that during this conference call, 00:01:03.361 -- 00:01:08.970 the company may make projections and forward-looking statements regarding future events. 00:01:08.970 -- 00:01:14.138 We encourage you to review the company's past and future filings with the SEC, including, 00:01:14.138 -- 00:01:19.222 without limitation, the company's annual report on Form 10-K, and 00:01:19.222 -- 00:01:24.628 quarterly reports on Forms 10Q, which identify the specific risk factors 00:01:24.628 -- 00...